KAIST researchers have developed and verified a deep learning algorithm, that can detect differences in gene expression patterns between tumor cells and normal cells based on logic circuits, to optimize chimeric antigen receptor (CAR) cell therapies.Identifying optimal target antigens that distingui
For Korea’s digital healthcare startups, especially artificial intelligence-based ones, to grow, the government must introduce a separate insurance coverage system for the sector, an industry executive said recently.A doctor-turned-investor said so on social media on Tuesday, causing quite a stir in
Lotte Biologics said it decided to introduce a stock option system for workers employed at the Korean headquarters.According to the biopharmaceutical unit of retail giant Lotte, it is the first time since the founding of the Lotte Group that an affiliate has provided stock options to all employees w
PSMC will change its name to HLB innoVation at a shareholder meeting next month to emerge as the HLB Group’s key unit in developing CAR-T (chimeric antigen receptor-T cell) treatments. In a public disclosure on Friday, PSMC said it would change its corporate title to HLB innovation by holding an ext
Celltrion has come forward to explain reasons for the delayed approval of its Humira biosimilar, Yuflyma (CT-P17), in the U.S., saying there were some problems, but they have been solved now.In a letter to shareholders published on its website Thursday, Celltrion said it has acquired a sales permit
The police said they arrested an employee of Samsung Biologics who tried to take out the company's classified data without permission.The Incheon Metropolitan Police Agency said Thursday that it is investigating the Samsung Biologics employee on charges of violating the Unfair Competition Prevention
A team of Korean researchers has revealed the function of the Dicer protein in generating microRNA (miRNA) for developing RNA therapeutics in two studies published simultaneously in the Nature journal.In particular, the first study highlighted how human dicer (hDICER) recognizes the precursor microR
Researchers at Seoul National University (SNU) College of Medicine found that those who consistently consumed foods made from soybeans such as tofu and soybean paste have a significantly lower risk of developing stomach cancer.A joint research team led by Professors Shin Woo-kyoung and Kang Dae-hee
Super-activated natural killer (SNK) therapy, a Korean NK-cell therapy, is expected to be used in pediatric sarcoma patients at MD Anderson Cancer Center, the developer of the therapy said. NKGen Biotech, a U.S. subsidiary of the Korean biotech firm NKMAX, said on Monday that MD Anderson Cancer Cent
Researchers in Korea have published a study demonstrating that the rate of frailty was 2.68 times higher in those who experience difficulty chewing food, emphasizing the importance of dental health.Frailty refers to the condition whereby physical functions weaken more rapidly than normal aging, incr
When it comes to cancer, except for blood cancer, it is generally diagnosed by biopsy. However, there is a way to diagnose cancer without a biopsy. Radiopharmaceuticals are the answer.The frontrunner in the Korean radiopharmaceutical market is DuoChemBio. Although a latecomer, it covers a full range
Bridge Biotherapeutics has failed to confirm the efficacy of its ulcerative colitis treatment BBT-401-1S in multinational phase 2a clinical trials.The company announced the result of the BBT-401-1S phase 2a clinical trial in a public filing on Friday. It conducted the trial on 38 moderate to severe
Eutilex, a Korean biotech firm, said it would conduct a clinical trial to develope a home-grown chimeric antigen receptor T cell (CAR-T) therapy. The company said on Wednesday the Ministry of Food and Drug Safety approved its plan to test EU307, an investigational CAR-T therapy in hepatocellular car
KAIST said on Wednesday that its researchers identified mutations present in trace amounts of brain cells in patients with local cortical dysplasia, an intractable epilepsy in children, laying the foundation for developing a treatment.Epilepsy is a neurological disorder characterized by repeated sei
As Samsung Bioepis won in the first trial to invalidate the patent of Alexion's rare intractable blood disease treatment Soliris (ingredient: eculizumab) in Korea, the possibility of Samsung Bioepis launching SB12, a biosimilar referencing Soliris in Korea has increased.To sell biosimilars, which ar
A team of researchers at the Korea Institute of Science and Technology (KIST) said they developed a biosensor that can distinguish small molecular neurotransmitters from body fluids like cerebrospinal fluids.Recently, excessive stress and increased life expectancy have caused an increase in mental d
Researchers in Korea have conducted a study that showed that regular exercise in type 2 diabetic patients reduces the risk of atrial fibrillation (AF), a type of arrhythmia that is the main cause of sudden death.Atrial fibrillation (AF) is a type of arrhythmia that causes rapid and irregular pulses
Samsung Biologics has officially asked the latecomer Lotte Biologics to stop talent poaching amid ongoing disputes over whether three ex-Samsung employees leaked Samsung’s trade secrets to Lotte, Yonhap News reported on Thursday. Samsung Biologics has sent three packs of certified mail to Lotte Biol
GenNBio expressed its goal to lead clinical trials of xenotransplantation of pancreatic islets globally and develop new treatment options for incurable diseases.The company held a press conference on Wednesday to update its development of pig pancreatic islet transplantation. The company hopes that
Celltrion Healthcare said it has recently hired Thomas Nusbickel, who has worked at multinational drugmakers such as Amgen and Pfizer, as Chief Commercial Officer (CCO) of Celltrion USA.According to Celltrion Healthcare, new CCO Nusbickel is an expert in sales, marketing, market access, and governme